Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Collateral gene inactivation biomarkers and targets for cancer therapy

Collateral gene inactivation biomarkers and targets for cancer therapy

US Patent 9452182 · Granted Sep 27, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tomato leaf curl new delhi virus (ToLCNDV) resistant melons2021
ZNF365/ZFP365 biomarker predictive of anti-cancer response2019
Enolase inhibitors and methods of treatment therewith2019
Enolase inhibitors and methods of treatment therewith2019
Methods for diagnosing and treating oncogenic kras-associated cancer2017
Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods 2017
Compositions and methods for the identification, assessment, prevention and ther2017
Signatures and determinants associated with prostate cancer progression and meth2016
Compositions, kits, and methods for identification, assessment, prevention, and 2016
Compositions, kits, and methods for identification, assessment, prevention and t2015
Compositions, kits, and methods for identification, assessment, prevention, and 2012
Compositions, kits and methods for identification, assessment, prevention and th2012